Latest Articles

Publication Date
Ending the Diagnostic Delay: Feinstein Institutes’ ROSE Study Continues to Advance Critical Endometriosis Diagnostic Test - joplinglobe.com

Ending the Diagnostic Delay: Feinstein Institutes’ ROSE Study Continues to Advance Critical Endometriosis Diagnostic Test joplinglobe.com

Published: March 31, 2026, 1:02 p.m.
Ending the Diagnostic Delay: Feinstein Institutes’ ROSE Study Continues to Advance Critical Endometriosis Diagnostic Test - Business Wire

Ending the Diagnostic Delay: Feinstein Institutes’ ROSE Study Continues to Advance Critical Endometriosis Diagnostic Test Business Wire

Published: March 31, 2026, 1 p.m.
Proteomic Analysis of Cervicovaginal Fluid for Diagnostic Endometriosis Biomarker Discovery.

Endometriosis is a prevalent inflammatory condition characterised by the presence of endometrial-like tissue outside the uterus and is associated with significant challenges, including diagnostic delays and continued reliance on laparoscopy. …

Published: March 31, 2026, midnight
Shared Pathophysiology and Early Detection Biomarkers in Endometriosis and Polycystic Ovary Syndrome (PCOS): Opportunities for AI-Enabled Screening.

Endometriosis and polycystic ovary syndrome (PCOS) are common, multifactorial gynecological disorders shaped by endocrine imbalance, immune dysfunction, metabolic disruption, genetic susceptibility, and environmental exposures. Despite their major contribution to infertility …

Published: March 28, 2026, midnight
ACOG Endometriosis Guidelines Target Diagnostic Delays.

Published: March 20, 2026, midnight
HerAnova Commercializes Blood Test for Endometriosis Detection, Targeting Years-Long Diagnostic Delays - R&D World

HerAnova Commercializes Blood Test for Endometriosis Detection, Targeting Years-Long Diagnostic Delays R&D World

Published: March 16, 2026, 9:31 p.m.
A SERRS-Based Lateral Flow Assay for Sensitive Detection of Mitochondrial DNA in Endometriosis Screening.

Endometriosis (EMT) is an incurable and painful chronic illness that affects approximately 10% of people assigned female at birth worldwide. Currently, EMT takes on average 5-7 years to diagnose after …

Published: March 12, 2026, midnight
Exosome-Enriched Hub Gene Networks Identify Diagnostic Biomarkers and Repurposable Therapeutic Targets in Endometriosis.

Endometriosis is a heterogeneous chronic inflammatory disorder associated with substantial diagnostic delay and limited therapeutic options, highlighting the need of robust non-invasive biomarkers and actionable molecular targets to complement existing …

Published: March 11, 2026, midnight
WOMEN'S HEALTH: Endometriosis awareness & reducing the diagnostic delay - FOX 17 West Michigan News

WOMEN'S HEALTH: Endometriosis awareness & reducing the diagnostic delay FOX 17 West Michigan News

Published: March 4, 2026, 12:38 p.m.
Digital symptom checkers could reduce diagnostic delay of endometriosis by 4 years - Contemporary OB/GYN

Digital symptom checkers could reduce diagnostic delay of endometriosis by 4 years Contemporary OB/GYN

Published: March 2, 2026, 10:07 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!